Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Shortages, inflation, agency utilization, and heightened union activity have created a perfect storm of workforce-related financial pressure for hospitals and health systems. In this...
The recent rise in labor costs is impacting operations for U.S. healthcare organizations. Listen to A&M Healthcare Industry Group's latest podcast to learn how...
In Part II of our podcast, the discussion continues and dives into the impact of COVID-19 on patient volume, specifically as it relates to...
